# Hypothesis on the role of cholesterol crystals in spontaneously ruptured aortic plaques: Potential triggers for inflammation and systemic effects

**Authors:** Chikao Yutani, Hirotaka Noda, Nobuzo Iwa, Sei Komatsu, Satoru Takahashi, Yoshiharu Higuchi, Kazuhisa Kodama

PMC · DOI: 10.1016/j.ahjo.2025.100507 · 2025-01-31

## TL;DR

This paper explores how cholesterol crystals in ruptured aortic plaques trigger inflammation and may lead to organ damage, suggesting potential treatments.

## Contribution

The paper introduces the IL-6 ratio as a novel metric to quantify inflammation in ruptured aortic plaques.

## Key findings

- Cholesterol crystals from ruptured aortic plaques activate the immune system and cause systemic inflammation.
- The IL-6 ratio reflects inflammation levels in individual plaques and could guide anti-inflammatory therapies.
- Non-obstructive angioscopy reveals the role of these plaques in chronic inflammation and organ decline.

## Abstract

Cholesterol crystals (CCs) are a key component of atherosclerotic plaques and play a pivotal role in plaque progression, rupture, and the resulting inflammatory responses. CCs emboli trigger proinflammatory cytokines which can potentially lead to organ damage. Spontaneously ruptured aortic plaques (SRAPs) are frequently observed via non-obstructive general angioscopy (NOGA) in patients with or suspected coronary artery disease. The release of CCs from SRAPs can activate the innate immune system and induce neutrophil extracellular trap (NET) formation, further exacerbating inflammation. Inflammation levels in SRAPs vary, and the interleukin (IL)-6 ratio may reflect the degree of inflammation. Systemic inflammation induced by CCs may contribute to conditions that may lead to cerebral infarction, and chronic kidney disease. The effects of anti-inflammatory drugs, including IL-6 inhibitors, IL-1β inhibitors, and colchicine, may be evaluated by measuring the IL-6 ratio in SRAPs. This review examined innate immunity mechanisms associated with CCs in SRAPs sampled via NOGA and discussed their systemic impact and potential therapeutic strategies.

•Cholesterol crystals drive inflammation and systemic impact via SRAPs.•IL-6 ratio quantifies inflammation levels in individual spontaneously ruptured aortic plaques.•CCs contribute to aging-related organ decline via embolism and immune activation.•NOGA reveals SRAPs' role in microemboli and chronic systemic inflammation.

Cholesterol crystals drive inflammation and systemic impact via SRAPs.

IL-6 ratio quantifies inflammation levels in individual spontaneously ruptured aortic plaques.

CCs contribute to aging-related organ decline via embolism and immune activation.

NOGA reveals SRAPs' role in microemboli and chronic systemic inflammation.

## Linked entities

- **Proteins:** IL6 (interleukin 6), IL1B (interleukin 1 beta)
- **Chemicals:** colchicine (PubChem CID 2833)
- **Diseases:** coronary artery disease (MONDO:0005010), cerebral infarction (MONDO:0002679), chronic kidney disease (MONDO:0005300)

## Full-text entities

- **Genes:** IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}
- **Diseases:** organ damage (MESH:D000092124), neutrophil extracellular (MESH:C535509), cerebral infarction (MESH:D002544), emboli (MESH:D020766), ruptured aortic plaques (MESH:D001019), Inflammation (MESH:D007249), atherosclerotic plaques (MESH:D058226), SRAPs (MESH:D012422), chronic kidney disease (MESH:D051436), coronary artery disease (MESH:D003324)
- **Chemicals:** colchicine (MESH:D003078), CCs (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11847121/full.md

---
Source: https://tomesphere.com/paper/PMC11847121